Dembinski Jennifer L, Krauss Stefan
Section for Cellular and Genetic Therapy, Institute of Microbiology, Cancer Stem Cell Innovation Center (CAST), Rikshospitalet, Forskiningsparken, Gaustadalléen 21, 0349, Oslo, Norway.
Clin Exp Metastasis. 2009;26(7):611-23. doi: 10.1007/s10585-009-9260-0. Epub 2009 May 7.
Evidence suggests that multiple tumors, including pancreatic adenocarcinoma, display heterogeneity in parameters that are critical for tumor formation, progression and metastasis. Understanding heterogeneity in solid tumors is increasingly providing a plethora of new diagnostic and therapeutic approaches. In this study, a particular focus was put on identifying a subpopulation of stem cell-like, slow cycling tumor cells in a pancreas adenocarcinoma cell lines. Using a label retention technique a subpopulation of slow cycling cells (DiI+/SCC) was identified and further evaluated in the BxPC-3 and Panc03.27 cell lines. These slowly cycling cells managed to retain the lipophilic labeling dye DiI, while the bulk of the cells (>94%) did not. The DiI+/SCC population, showed only a partial overlap with the CSC markers CD24(+)/CD44(+), CD133(+) and ALDH but they survived chemotherapeutic treatment, and were able to recreate the initial heterogeneous tumor cell population. DiI+/SCCs exhibited an increased invasive potential as compared with their non-label retaining, faster cycling cells (DiI-/FCC). They also had increased tumorigenic potential and morphological changes resembling cells that have undergone an epithelial to mesenchymal transition (EMT). Analysis of DiI+/SCC cells by real time PCR revealed a selective up-regulation of tell tale components of the Hedgehog/TGFbeta pathways, as well as a down-regulation of EGFR, combined with a shift in crucial components implied in EMT. The presented findings offer an expanded mechanistic understanding that associates tumor initiating potential with cycling speed and EMT in pancreatic cancer cell lines.
有证据表明,包括胰腺腺癌在内的多种肿瘤在对肿瘤形成、进展和转移至关重要的参数方面表现出异质性。对实体瘤异质性的理解正日益提供大量新的诊断和治疗方法。在本研究中,特别关注在胰腺腺癌细胞系中鉴定出一类干细胞样、慢周期肿瘤细胞亚群。使用标记保留技术在BxPC - 3和Panc03.27细胞系中鉴定出慢周期细胞亚群(DiI + / SCC)并进行进一步评估。这些慢周期细胞能够保留亲脂性标记染料DiI,而大部分细胞(> 94%)则不能。DiI + / SCC群体仅与CSC标志物CD24( + ) / CD44( + )、CD133( + )和ALDH部分重叠,但它们在化疗后存活下来,并能够重新形成最初的异质性肿瘤细胞群体。与非标记保留、快速增殖细胞(DiI - / FCC)相比,DiI + / SCC表现出更高的侵袭潜力。它们还具有更高的致瘤潜力以及类似于经历上皮 - 间质转化(EMT)的细胞的形态变化。通过实时PCR对DiI + / SCC细胞进行分析,发现刺猬信号通路/转化生长因子β信号通路的典型成分选择性上调,同时表皮生长因子受体下调,同时EMT中关键成分发生转变。所呈现的研究结果提供了一种扩展的机制理解,将肿瘤起始潜力与胰腺癌细胞系中的增殖速度和EMT联系起来。